PAVmed Return on Equity (ROE) Growth & History (PAVM)

PAVmed's return on equity was 2.55% for fiscal 2025.

View full PAVmed company overview

PAVmed annual return on equity history

PAVmed annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-312.55%
20222022-12-31−342.34%−183.92 pp
20212021-12-31−158.42%
20162016-12-31−3,589.54%

PAVmed return on equity trends

Between the periods ended 2016-12-31 and 2025-12-31, PAVmed's return on equity increased from −3,589.54% to 2.55%, a change of +3592.09 percentage points. The latest reported quarter, Q2 2026, shows −14.44%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review PAVmed source filings ↗

Community posts

It’s quiet here.

No posts about PAVM yet. Start the conversation.

Write the first post